First Trust Health Care AlphaDEX Fund (FXH) Holdings $104.17 +0.03 (+0.03%) As of 03/27/2025 04:10 PM Eastern Add Compare Share Share Holdings Stock AnalysisChartDividendHoldingsOwnershipRatingsBuy This Stock Top 78 FXH HoldingsRankCompanyCurrent PriceWeightShares Held1RPRXRoyalty Pharma$31.65+0.3%2.89%849,1692ITCIIntra-Cellular Therapies$131.75+0.0%2.78%207,4933DOCSDoximity$60.59-1.5%2.53%405,7364JAZZJazz Pharmaceuticals$126.40-3.4%2.50%175,9015CAHCardinal Health$136.90+2.2%2.45%183,1616EXELExelixis$36.84-0.5%2.41%650,5197THCTenet Healthcare$134.41+1.0%2.19%171,6098CNCCentene$60.23-0.5%2.17%357,5829UHSUniversal Health Services$186.27+1.0%2.17%120,73510ELVElevance Health$431.81+0.3%2.09%46,978 Get the Latest News and Ratings for FXH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for First Trust Health Care AlphaDEX Fund and its competitors with MarketBeat's FREE daily newsletter. 11BIIBBiogen$140.33-1.5%2.06%141,65712PENPenumbra$268.89-2.3%2.05%72,97413NTRANatera$148.30-1.0%2.04%136,84314DGXQuest Diagnostics$166.13-0.3%2.02%114,87415ROIVRoivant Sciences$10.48+0.4%2.00%1,831,13216ELANElanco Animal Health$10.81+2.4%1.97%1,788,79417UTHRUnited Therapeutics$308.02-0.9%1.96%61,39518PINCPremier$19.19+0.9%1.93%1,021,80719MOHMolina Healthcare$323.85+0.1%1.92%59,54320ZBHZimmer Biomet$112.20+1.4%1.89%164,06221OGNOrganon & Co.$14.57-1.0%1.86%1,161,51822MASIMasimo$168.47+1.2%1.80%104,83823DVADaVita$152.73+0.9%1.76%115,47024PODDInsulet$260.27-1.7%1.75%66,13725CRLCharles River Laboratories International$158.250.0%1.69%93,54426REGNRegeneron Pharmaceuticals$635.83-0.7%1.65%24,32927ISRGIntuitive Surgical$507.90-0.2%1.64%33,20128ACHCAcadia Healthcare$30.12+1.6%1.62%544,37729CIThe Cigna Group$324.74+1.1%1.54%46,89630MDTMedtronic$89.00+0.9%1.52%162,12731CHEChemed$612.09+0.5%1.51%24,44032HOLXHologic$62.32+1.4%1.51%239,52733JNJJohnson & Johnson$163.22+0.9%1.50%89,54834VEEVVeeva Systems$237.52+0.8%1.48%61,60335HCAHCA Healthcare$341.94+1.4%1.45%43,14436HUMHumana$270.04-0.2%1.40%51,04537EHCEncompass Health$101.19+0.8%1.39%140,23438SYKStryker$367.87+0.0%1.38%35,97539HSICHenry Schein$69.40-0.5%1.37%187,14640VTRSViatris$8.84-1.3%1.34%1,386,954Elon Warns: Exec Order 14024 Targets Dollar (Ad)Executive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth, your savings, and your retirement. When the dollar collapses, your savings could disappear overnight. With Trump threatening Russia with more sanctions, Russia is rushing to finalize their BRICS payment system aimed to destroy the U.S dollar.Go Here to Learn What's Happening and How to Prepare >>41PFEPfizer$25.05-0.6%1.31%488,15942RMDResMed$222.62+0.3%1.27%56,62743INCYIncyte$60.68-0.9%1.15%187,49644NBIXNeurocrine Biosciences$114.00-0.4%1.06%94,88245TFXTeleflex$139.34-0.6%1.04%72,76746ABTAbbott Laboratories$131.67+4.0%0.98%76,33447PRGOPerrigo$27.74+1.4%0.95%335,81248GEHCGE HealthCare Technologies$81.66+0.8%0.92%110,42849LHLaboratory Co. of America$231.65-0.7%0.92%37,65550WATWaters$370.19+0.7%0.91%23,28051BDXBecton, Dickinson and Company$228.76+0.3%0.90%38,05452RVTYRevvity$107.41+0.0%0.89%77,35253TMOThermo Fisher Scientific$511.69-0.4%0.88%16,59254UNHUnitedHealth Group$515.89-0.4%0.88%17,07255EWEdwards Lifesciences$71.17+0.1%0.84%116,62156IQVIQVIA$179.40-0.3%0.84%43,93557AAgilent Technologies$119.04-0.7%0.81%64,26458ENOVEnovis$38.89-0.8%0.78%196,76259INSPInspire Medical Systems$160.80-1.5%0.77%46,57560SRPTSarepta Therapeutics$71.81-1.5%0.53%71,00361BAXBaxter International$33.76+1.2%0.49%138,79262STESTERIS$224.35+0.6%0.46%19,69263BMRNBioMarin Pharmaceutical$72.83+1.9%0.45%61,57564LLYEli Lilly and Company$822.14-0.6%0.44%5,24365ALNYAlnylam Pharmaceuticals$271.02+0.7%0.43%17,19966ZTSZoetis$165.12+1.4%0.42%24,83767MEDPMedpace$316.61-0.3%0.40%12,18468DHRDanaher$210.26-0.1%0.38%17,63569DXCMDexCom$69.47-3.7%0.37%52,04370COOCooper Companies$84.98+1.3%0.36%44,03071ALGNAlign Technology$164.29-1.3%0.33%19,40672AVTRAvantor$16.17-0.7%0.33%192,08173BRKRBruker$43.45-0.1%0.33%69,04374EXASExact Sciences$44.99+0.2%0.33%72,02875APLSApellis Pharmaceuticals$24.28+2.1%0.32%126,83276WSTWest Pharmaceutical Services$226.15+0.6%0.30%12,35677Morgan Stanley Institutional Liquidity Funds - Treasury PortfolioN/A0.07%690,75778Securities Lending - BnymN/A0.00%1 Geographic ExposureUnited States92.9%Ireland5.2%Bermuda2.0%Currency ExposureUSD90.6%Sector ExposureHealth Care85.4%Technology1.5%Consumer Discretionary1.1%Industry ExposureHealth Care Providers & Services31.1%Health Care Equipment & Supplies25.0%Biotechnology18.2%Pharmaceuticals5.2%Health Care Technology3.9%Software1.5%Diversified Consumer Services1.2%Life Sciences Tools & Services0.3%Distributors0.3%SubIndustry ExposureBiotechnology18.5%Health Care Equipment16.4%Health Care Services11.5%Health Care Facilities11.0%Managed Health Care8.6%Life Sciences Tools & Services6.1%Pharmaceuticals5.2%Health Care Supplies4.0%Health Care Distributors3.9%Application Software1.5% Related Companies and Tools Related Companies RYH Portfolio Companies FBT Portfolio Companies RSPH Portfolio Companies LABU Portfolio Companies IHF Portfolio Companies PPH Portfolio Companies IHE Portfolio Companies BBH Portfolio Companies PJP Portfolio Companies PBE Portfolio Companies This page (NYSEARCA:FXH) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersA $6.9 Trillion Cash Tsunami Is Coming – Move Your Money NOWExpert: "Prepare For the Mother of All Melt-Ups" In the wake of Wall Street volatility, stock-picking legen...Stansberry Research | SponsoredElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredNvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry."If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding First Trust Health Care AlphaDEX Fund Please log in to your account or sign up in order to add this asset to your watchlist. Share First Trust Health Care AlphaDEX Fund With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
